Connection

JOYDIP DAS to Humans

This is a "connection" page, showing publications JOYDIP DAS has written about Humans.
Connection Strength

0.267
  1. Kratom Alkaloids for the Treatment of Alcohol Use Disorder. ACS Chem Neurosci. 2024 12 18; 15(24):4352-4359.
    View in: PubMed
    Score: 0.026
  2. Modulation of proteasome activity by curcumin and didemethylcurcumin. J Biomol Struct Dyn. 2022 11; 40(18):8332-8339.
    View in: PubMed
    Score: 0.020
  3. Probing the Diacylglycerol Binding Site of Presynaptic Munc13-1. Biochemistry. 2021 Apr 27; 60(16):1286-1298.
    View in: PubMed
    Score: 0.020
  4. Repurposing of Drugs-The Ketamine Story. J Med Chem. 2020 11 25; 63(22):13514-13525.
    View in: PubMed
    Score: 0.020
  5. Effect of ethanol on Munc13-1 C1 in Membrane: A Molecular Dynamics Simulation Study. Alcohol Clin Exp Res. 2020 07; 44(7):1344-1355.
    View in: PubMed
    Score: 0.019
  6. SNARE Complex-Associated Proteins and Alcohol. Alcohol Clin Exp Res. 2020 01; 44(1):7-18.
    View in: PubMed
    Score: 0.019
  7. Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta. Biochim Biophys Acta Biomembr. 2018 May; 1860(5):1046-1056.
    View in: PubMed
    Score: 0.016
  8. Case-based studies in teaching medicinal chemistry in PharmD curriculum: Perspectives of students, faculty, and pharmacists from academia. Curr Pharm Teach Learn. 2018 Jan - Feb; 10(1):85-89.
    View in: PubMed
    Score: 0.016
  9. Resveratrol inhibits phorbol ester-induced membrane translocation of presynaptic Munc13-1. Biochim Biophys Acta Gen Subj. 2017 Nov; 1861(11 Pt A):2640-2651.
    View in: PubMed
    Score: 0.016
  10. Curcumin Inhibits Protein Kinase Ca Activity by Binding to Its C1 Domain. Biochemistry. 2016 Nov 15; 55(45):6327-6336.
    View in: PubMed
    Score: 0.015
  11. Polyphenol compounds and PKC signaling. Biochim Biophys Acta. 2016 10; 1860(10):2107-21.
    View in: PubMed
    Score: 0.015
  12. Novel N-pyrimidin-4-yl-3-amino-pyrrolo [3, 4-C] pyrazole derivatives as PKC kinase inhibitors: a patent evaluation of US2015099743 (A1). Expert Opin Ther Pat. 2016; 26(4):523-8.
    View in: PubMed
    Score: 0.014
  13. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain. J Biomol Struct Dyn. 2015; 33(1):219-32.
    View in: PubMed
    Score: 0.012
  14. PKC activation by resveratrol derivatives with unsaturated aliphatic chain. PLoS One. 2012; 7(12):e52888.
    View in: PubMed
    Score: 0.011
  15. Chemical modifications of resveratrol for improved protein kinase C alpha activity. Bioorg Med Chem. 2011 Sep 15; 19(18):5321-33.
    View in: PubMed
    Score: 0.010
  16. PKC epsilon has an alcohol-binding site in its second cysteine-rich regulatory domain. Biochem J. 2009 Jul 15; 421(3):405-13.
    View in: PubMed
    Score: 0.009
  17. Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase Cd*. Biophys J. 2012 Dec 05; 103(11):2331-40.
    View in: PubMed
    Score: 0.003
  18. Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-?B (NF-?B) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-?B a kinase activation, leading to suppression of NF-?B-regulated gene expression and sensitization of tumor cells to chemotherapeutic agents. Mol Pharmacol. 2011 Nov; 80(5):769-81.
    View in: PubMed
    Score: 0.003
  19. Alcohol-binding sites in distinct brain proteins: the quest for atomic level resolution. Alcohol Clin Exp Res. 2011 Sep; 35(9):1561-73.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.